Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,910 | 140 | 99.7% |
| Education | $12.79 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merz North America, Inc. | $675.00 | 3 | $0 (2019) |
| Abbott Laboratories | $601.90 | 12 | $0 (2024) |
| Boston Scientific Corporation | $460.13 | 8 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $206.24 | 13 | $0 (2023) |
| Amgen Inc. | $191.62 | 5 | $0 (2024) |
| Allergan, Inc. | $139.49 | 9 | $0 (2022) |
| GlaxoSmithKline, LLC. | $139.32 | 9 | $0 (2022) |
| UPSHER-SMITH LABORATORIES LLC | $137.59 | 7 | $0 (2023) |
| Amarin Pharma Inc. | $129.78 | 6 | $0 (2022) |
| PFIZER INC. | $124.15 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $305.54 | 5 | Abbott Laboratories ($176.54) |
| 2023 | $374.65 | 20 | ABBVIE INC. ($98.13) |
| 2022 | $796.38 | 41 | Abbott Laboratories ($99.94) |
| 2021 | $791.82 | 42 | Abbott Laboratories ($124.05) |
| 2020 | $223.29 | 9 | Boston Scientific Corporation ($85.56) |
| 2019 | $510.10 | 4 | Merz North America, Inc. ($475.00) |
| 2018 | $503.85 | 11 | Merz North America, Inc. ($200.00) |
| 2017 | $417.30 | 9 | BOSTON SCIENTIFIC CORPORATION ($336.37) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Abbott Laboratories | CONFIRM RX (Device) | Food and Beverage | In-kind items and services | $43.29 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/13/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $107.62 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/13/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: Cardiac Rhythm Management | ||||||
| 03/13/2024 | Philips North America LLC | (9148) ICE 3D (Device) | Food and Beverage | Cash or cash equivalent | $16.51 | General |
| Category: Medical Device | ||||||
| 02/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $112.49 | General |
| Category: Cardiology | ||||||
| 12/14/2023 | ABBVIE INC. | NATRELLE SALINE-FILLED BREAST IMPLANTS (Device) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: PLASTIC SURGERY | ||||||
| 11/22/2023 | Philips Electronics North America Corporation | (5050) Ext Holter (Device) | Food and Beverage | Cash or cash equivalent | $21.78 | General |
| Category: Medical Device | ||||||
| 08/21/2023 | Abbott Laboratories | CONFIRM RX (Device) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Cardiac Rhythm Management | ||||||
| 06/27/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: FACIAL AESTHETICS | ||||||
| 05/04/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: DIABETES | ||||||
| 04/21/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/20/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/04/2023 | UPSHER-SMITH LABORATORIES LLC | ZEMBRACE SYMTOUCH (Drug), TOSYMRA | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: NEUROLOGY | ||||||
| 03/21/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.21 | General |
| Category: PSYCHIATRY | ||||||
| 03/09/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 03/07/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Diabetes | ||||||
| 02/28/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Oncology | ||||||
| 02/23/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Diabetes | ||||||
| 02/21/2023 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $19.70 | General |
| 02/13/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/25/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: FACIAL AESTHETICS | ||||||
| 01/19/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Respiratory | ||||||
| 01/17/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $31.03 | General |
| Category: NEUROSCIENCE | ||||||
| 01/04/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: FACIAL AESTHETICS | ||||||
| 01/03/2023 | UPSHER-SMITH LABORATORIES LLC | ZEMBRACE SYMTOUCH (Drug), TOSYMRA | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 186 | 304 | $109,606 | $25,600 |
| 2022 | 8 | 321 | 683 | $168,820 | $52,859 |
| 2021 | 7 | 386 | 594 | $175,390 | $52,118 |
| 2020 | 8 | 412 | 576 | $185,945 | $45,570 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 145 | 207 | $80,171 | $16,998 | 21.2% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 72 | $22,380 | $7,131 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 25 | $7,055 | $1,471 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 178 | 326 | $102,690 | $30,296 | 29.5% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 22 | 112 | $29,680 | $11,466 | 38.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 16 | 73 | $9,490 | $3,187 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 52 | $11,180 | $2,893 | 25.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 14 | 69 | $7,245 | $2,717 | 37.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 15 | $6,375 | $1,854 | 29.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 21 | 24 | $1,680 | $265.94 | 15.8% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2022 | 12 | 12 | $480.00 | $181.93 | 37.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 127 | 172 | $73,100 | $22,047 | 30.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 139 | 204 | $64,260 | $18,720 | 29.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 50 | $10,750 | $3,277 | 30.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2021 | 15 | 69 | $8,970 | $3,020 | 33.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 18 | 18 | $10,890 | $2,918 | 26.8% |
| 99457 | Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; first 20 minutes | Office | 2021 | 15 | 50 | $5,250 | $1,800 | 34.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 27 | 31 | $2,170 | $336.84 | 15.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 123 | 177 | $75,225 | $18,634 | 24.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 143 | 223 | $70,245 | $16,458 | 23.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 29 | 29 | $17,545 | $4,762 | 27.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 41 | 46 | $9,890 | $2,401 | 24.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2020 | 12 | 33 | $4,290 | $1,678 | 39.1% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2020 | 18 | 18 | $5,580 | $944.10 | 16.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 35 | 39 | $2,730 | $525.82 | 19.3% |
About Dr. David Engleman, MD
Dr. David Engleman, MD is a Internal Medicine healthcare provider based in Irving, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427095603.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Engleman, MD has received a total of $3,923 in payments from pharmaceutical and medical device companies, with $305.54 received in 2024. These payments were reported across 141 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($3,910).
As a Medicare-enrolled provider, Engleman has provided services to 1,305 Medicare beneficiaries, totaling 2,157 services with total Medicare billing of $176,147. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Irving, TX
- Active Since 05/31/2006
- Last Updated 08/24/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1427095603
Products in Payments
- XEOMIN (Biological) $175.00
- BOTOX (Biological) $168.56
- EMBLEM S-ICD (Device) $167.99
- CONFIRM RX (Device) $160.76
- NURTEC ODT (Drug) $144.12
- AVEIR (Device) $133.25
- Vascepa (Drug) $129.78
- TRELEGY ELLIPTA (Drug) $126.36
- Confirm Rx (Device) $124.05
- FARXIGA (Drug) $117.90
- EMBLEM (Device) $115.42
- Repatha (Biological) $112.49
- VIGILANT (Device) $102.60
- Merlin Connectivity and Remote (Device) $84.28
- ZEMBRACE SYMTOUCH (Drug) $79.58
- XARELTO (Drug) $68.83
- REXULTI (Drug) $68.16
- ELIQUIS (Drug) $66.72
- INOGEN (Device) $64.29
- Otezla (Drug) $62.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Irving
Dr. Samata Basani, M.d, M.D
Internal Medicine — Payments: $302,290
Dr. Shiraj Sen, M.d, M.D
Internal Medicine — Payments: $81,865
Branden Snyder, M.d, M.D
Internal Medicine — Payments: $29,735
Ahmed Iqbal, M.d, M.D
Internal Medicine — Payments: $24,674
Nauman Siddiqi, Md, MD
Internal Medicine — Payments: $19,851
Dr. Enid Romanelli, M.d, M.D
Internal Medicine — Payments: $14,115